Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 69251-69300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06012864
Supine Versus Prone PNL in Pediatric
NANot yet recruiting
100 participants
Started: Aug 30, 2023 · Completed: Aug 30, 2026
1 condition1 sponsor1 location
NCT06003101
Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
PHASE3Recruiting
160 participants
Started: Aug 30, 2023 · Completed: Aug 30, 2045
4 conditions1 sponsor1 location
NCT05470439
My Interprofessional Care Team for Adherence and Research Engagement Disparities
NARecruiting
230 participants
Started: Aug 30, 2023 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT06555965
STXBP1 and SYNGAP1 Related Disorders Natural History Study
N/ARecruiting
400 participants
Started: Aug 30, 2023 · Completed: Dec 30, 2028
3 conditions2 sponsors5 locations
NCT05998005
First Face Training Evaluation in Tribal Communities
NARecruiting
1,000 participants
Started: Aug 30, 2023 · Completed: Jun 1, 2026
2 conditions3 sponsors9 locations
NCT05709899
Comparison of Ultrasound-guided Erector Spinae Plane Block and Transmuscular Quadratus Lumborum Block
NANot yet recruiting
44 participants
Started: Aug 30, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT06096896
The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study
N/AActive, not recruiting
334 participants
Started: Aug 30, 2023 · Completed: Sep 30, 2030
1 condition1 sponsor1 location
NCT05957016
Neoadjuvant CIETAI With Concurrent Chemoradiotherapy in Local Advanced Rectal Cancer
PHASE2Recruiting
90 participants
Started: Aug 30, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05693129
Pediatric Patients Aged 1 to 6 Years With APDS
PHASE3Active, not recruiting
16 participants
Started: Aug 30, 2023 · Completed: Feb 28, 2026
1 condition5 sponsors9 locations
NCT06074406
Low-Field Bedside Brain Magnetic Resonance Imaging in Pediatric Extracorporeal Membrane Oxygenation
NAActive, not recruiting
20 participants
Started: Aug 30, 2023 · Completed: Aug 30, 2026
3 conditions1 sponsor1 location
NCT05934981
Laparoscopic Colorectal Surgery Using Low-pressure Combined With Warm and Humidified Carbon Dioxide Insufflation
NARecruiting
148 participants
Started: Aug 30, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor2 locations
NCT05852262
High-dose Cephalexin for Cellulitis (HI-DOCC)
PHASE4Enrolling by invitation
446 participants
Started: Aug 30, 2023 · Completed: Aug 1, 2026
1 condition3 sponsors10 locations
NCT05504902
Vibrotactile Coordinated Reset for the Treatment of Advanced Parkinson's Disease
NAEnrolling by invitation
35 participants
Started: Aug 30, 2023 · Completed: Nov 1, 2026
1 condition1 sponsor1 location
NCT05309928
Phase 1 Study of the Pharmacokinetics of Amoxicillin in Pregnancy
PHASE1Recruiting
20 participants
Started: Aug 29, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05885412
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
PHASE1Recruiting
9 participants
Started: Aug 29, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor3 locations
NCT05825014
Predicting Adverse Outcomes Using Machine Learning of COPD Patients in Hong Kong
N/ARecruiting
100,000 participants
Started: Aug 29, 2023 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT06333964
A Study to Evaluate the Efficacy and Safety of AST-001 in ASD Children
PHASE3Active, not recruiting
169 participants
Started: Aug 29, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor11 locations
NCT06013956
Personalized Real-Time DBS and PD Mechanisms
PHASE4Recruiting
25 participants
Started: Aug 29, 2023 · Completed: Jun 30, 2028
1 condition2 sponsors1 location
NCT05761951
Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
PHASE2Recruiting
60 participants
Started: Aug 29, 2023 · Completed: Jan 31, 2029
1 condition4 sponsors1 location
NCT05754580
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer
NARecruiting
53 participants
Started: Aug 29, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT05949281
Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes
PHASE2Active, not recruiting
100 participants
Started: Aug 29, 2023 · Completed: Jun 15, 2026
3 conditions3 sponsors1 location
NCT05975619
A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System
NAActive, not recruiting
40 participants
Started: Aug 29, 2023 · Completed: Apr 30, 2026
4 conditions1 sponsor1 location
NCT05975580
Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery
PHASE4Recruiting
120 participants
Started: Aug 29, 2023 · Completed: Jul 31, 2027
1 condition2 sponsors1 location
NCT05965258
Phenotypic Classification of FMR With CMR
N/ARecruiting
360 participants
Started: Aug 29, 2023 · Completed: Dec 31, 2028
3 conditions2 sponsors1 location
NCT05819931
Breathing with Amyotrophic Lateral Sclerosis
NARecruiting
36 participants
Started: Aug 29, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06691776
Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)
NARecruiting
100 participants
Started: Aug 29, 2023 · Completed: Dec 1, 2028
5 conditions1 sponsor1 location
NCT05679739
NEUROprotection Via optimizINg Cerebral Blood Flow afTer cArdiaC arresT (NEURO-INTACT) Study
NARecruiting
49 participants
Started: Aug 29, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05993546
Randomized Controlled Trial of Miniaturized Percutaneous Nephrolithotomy With Vacuum-Assisted Access Sheaths Versus Conventional Sheaths for Treatment of Nephrolithiasis
NARecruiting
90 participants
Started: Aug 29, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05584007
Cellulitis Optimal Antibiotic Treatment
PHASE3Recruiting
356 participants
Started: Aug 29, 2023 · Completed: Oct 1, 2026
1 condition5 sponsors1 location
NCT06002425
Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
NARecruiting
400 participants
Started: Aug 29, 2023 · Completed: Dec 31, 2028
1 condition8 sponsors7 locations
NCT05033379
Healthcare Worker Resilience as Measured by Physiologic Feedback
NAActive, not recruiting
400 participants
Started: Aug 29, 2023 · Completed: Jun 30, 2024
1 condition2 sponsors1 location
NCT06114017
Effect of a Week-long Social Media Abstention on Sustained Attention Functions
NARecruiting
50 participants
Started: Aug 29, 2023 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT05813392
Digital Cognitive Behavioral Therapy for Insomnia for Chronic Insomnia in Breast Cancer Survivors
NARecruiting
264 participants
Started: Aug 29, 2023 · Completed: Aug 29, 2026
1 condition2 sponsors1 location
NCT06313424
Arthroscopic Treatment of Meniscal Lesions on Healthy Meniscus in Children and Adolescents
N/ARecruiting
120 participants
Started: Aug 29, 2023 · Completed: Apr 29, 2024
1 condition1 sponsor1 location
NCT06163053
A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home
N/ARecruiting
150 participants
Started: Aug 29, 2023 · Completed: Feb 28, 2025
2 conditions1 sponsor3 locations
NCT04876651
The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only
PHASE3Recruiting
392 participants
Started: Aug 29, 2023 · Completed: Dec 1, 2028
1 condition1 sponsor6 locations
NCT05942638
Longitudinal Assessment of Post-concussion Driving in Young Adults
N/AEnrolling by invitation
1,000 participants
Started: Aug 29, 2023 · Completed: Jun 30, 2028
3 conditions4 sponsors1 location
NCT05978661
FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
PHASE1Recruiting
12 participants
Started: Aug 29, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05903339
Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIV
PHASE1Active, not recruiting
36 participants
Started: Aug 29, 2023 · Completed: Dec 21, 2025
1 condition1 sponsor6 locations
NCT06013592
Gut Hormone LEAP2 in Metabolism and Eating Behaviour: Fixed Meal Testing
NARecruiting
30 participants
Started: Aug 29, 2023 · Completed: Aug 31, 2025
3 conditions1 sponsor1 location
NCT05747469
Use of Allograft Adipose Matrix for Small Joint Arthritis of the Hand
EARLY_PHASE1Recruiting
20 participants
Started: Aug 28, 2023 · Completed: Jan 31, 2025
1 condition2 sponsors1 location
NCT05361486
Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru
N/ARecruiting
40 participants
Started: Aug 28, 2023 · Completed: Oct 31, 2024
1 condition4 sponsors1 location
NCT06008379
A Study of 7MW3711 in Subjects With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
164 participants
Started: Aug 28, 2023 · Completed: Jan 30, 2026
1 condition1 sponsor5 locations
NCT05713838
Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery
PHASE2Recruiting
32 participants
Started: Aug 28, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor22 locations
NCT05894655
Community-engaged Optimization of COVID-19 Rapid Evaluation and TEsting Experiences
NARecruiting
7,500 participants
Started: Aug 28, 2023 · Completed: Feb 28, 2025
2 conditions2 sponsors1 location
NCT05990491
Pituitary Function After Recovery From Septic Shock Among ICU Survivors
N/ARecruiting
90 participants
Started: Aug 28, 2023 · Completed: Aug 31, 2025
3 conditions1 sponsor2 locations
NCT05041647
Cannabinoids As a Treatment for Insomnia in Major Depression
PHASE2Active, not recruiting
60 participants
Started: Aug 28, 2023 · Completed: Feb 28, 2025
5 conditions2 sponsors1 location
NCT05681026
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
NARecruiting
60 participants
Started: Aug 28, 2023 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT05685368
Acceptance and Commitment Therapy (ACT) for Combating the Effects of Race-Related Stress Among Black Adolescents
NARecruiting
30 participants
Started: Aug 28, 2023 · Completed: Jul 31, 2024
4 conditions1 sponsor1 location
NCT05928312
Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer
NANot yet recruiting
72 participants
Started: Aug 28, 2023 · Completed: Jun 1, 2026
1 condition1 sponsor1 location